Editorial
Review Article
Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma
Editorial Commentary
Interviews with Outstanding Guest Editors1
Disclosure:
1. The series “Interviews with Outstanding Guest Editors” was commissioned by the editorial office, Chinese Clinical Oncology without any funding or sponsorship.
![](http://cdn.amegroups.cn/journals/amepc/public/journals/12/cover_issue_1283_54_en_US.jpg/w800)